Fitbit, Inc. has received US Food and Drug Administration clearance and the European Union's CE mark for its electrocardiogram app to assess users’ heart rhythms for atrial fibrillation (AFib) with a launch planned for October.
“Early detection of AFib is critical, and I’m incredibly excited that we are making these innovations accessible to people around...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?